Retatrutide 30mg – Research Peptide
Retatrutide 30mg is supplied as a high-purity lyophilized synthetic peptide formulated for laboratory research involving incretin receptor signaling and advanced metabolic pathway investigation. In controlled experimental environments, this compound is studied for its interaction with GLP-1, GIP, and glucagon receptor systems.
Retatrutide 30mg research peptide is supplied as a high-purity lyophilized synthetic compound for laboratory research applications.
We’ve published a detailed research comparison examining Retatrutide vs Tirzepatide in laboratory settings, including receptor targeting differences and signaling pathway considerations.
Read the full comparison here.
Research Applications
Retatrutide is evaluated in research models for:
• Triple receptor pathway engagement
• cAMP signaling modulation
• Intracellular metabolic cascade analysis
• Receptor interaction mapping
Its multi-receptor activation profile distinguishes it from dual-agonist compounds studied in related incretin research environments.
Product Specifications
• Compound: Retatrutide
• Strength: 30mg per via
l• Form: Lyophilized powder
• Purity: Research-grade (see COA)
• Storage: Refrigerated conditions recommended
• Intended Use: Laboratory Research Use Only
Certificate of Analysis
Each vial includes a QR code linking to the current Certificate of Analysis for batch
transparency and purity verification.
Current Active Batch: # ERL-2501-B007-T
Research Use Notice
This compound is supplied strictly for laboratory research use only. Not for human or animal consumption
Related Metabolic Research Peptides
Researchers studying Retatrutide may also examine:
ERL-2501-B007-T
